D
Avicanna Inc.
AVCNF
OTC PK
$0.2958 $0.0144.97% Volume2,040 05/27/2022 1:13PM Eastern Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
--
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 12, 2022
Period Date
Thursday, March 31, 2022
Next Filing
Beginning of September (est)
Price History
Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Phone Number
Address
480 University Avenue
Toronto, ON M5G 1V2
Country
Year Founded
Business Description
Sector
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The... more
Weiss Ratings